Back to trial detailsIntake questionnaire
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Applying to Tucson Clinical Research Institute · Tucson, Arizona
Answer a few short questions to share with the research team.
0 of 4 answered